Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.
Journal: Pediatric hematology and oncology
Published: December 07, 2017
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).
Journal: Pediatric blood & cancer
Published: September 09, 2016
Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.
Journal: Angewandte Chemie (International ed. in English)
Published: July 24, 2015
CNS prophylaxis in pediatric acute lymphoblastic leukemia.
Journal: Hematology. American Society of Hematology. Education Program
Published: February 20, 2015
Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
Journal: Oncotarget
Published: October 22, 2014
Does hematopoietic stem cell transplantation benefit infants with acute leukemia?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 10, 2013
Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.
Journal: Molecular cancer research : MCR
Published: June 12, 2013
MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
Journal: British journal of haematology
Published: October 01, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026